{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:21:57Z","timestamp":1788142917424,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bcp.2019.04.020","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T19:05:58Z","timestamp":1555614358000},"page":"263-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Comprehensive study of thiopurine methyltransferase genotype, phenotype, and genotype-phenotype discrepancies in Sweden"],"prefix":"10.1016","volume":"164","author":[{"given":"Anna","family":"Zimdahl Kahlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Helander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Skoglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"S\u00f6derkvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-G\u00f6ran","family":"M\u00e5rtensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin Lindqvist","family":"Appell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcp.2019.04.020_b0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/157016006778992813","article-title":"Thiopurines in inflammatory bowel disease-the role of pharmacogenetics and therapeutic drug monitoring","volume":"4","author":"Lindqvist","year":"2006","journal-title":"Curr. Pharmacogenom."},{"issue":"8","key":"10.1016\/j.bcp.2019.04.020_b0010","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00228-008-0478-6","article-title":"Clinical pharmacology and pharmacogenetics of thiopurines","volume":"64","author":"Sahasranaman","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2019.04.020_b0015","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.bcp.2010.01.006","article-title":"Thiopurines: factors influencing toxicity and response","volume":"79","author":"Fotoohi","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2019.04.020_b0020","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00228-012-1251-4","article-title":"Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia","volume":"68","author":"Adam de Beaumais","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2019.04.020_b0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/FPC.0b013e32835f1cc0","article-title":"Nomenclature for alleles of the thiopurine methyltransferase gene","volume":"23","author":"Appell","year":"2013","journal-title":"Pharmacogenet. Genom."},{"issue":"5","key":"10.1016\/j.bcp.2019.04.020_b0030","first-page":"651","article-title":"Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity","volume":"32","author":"Weinshilboum","year":"1980","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcp.2019.04.020_b0035","doi-asserted-by":"crossref","unstructured":"H.-Y. Kim, S.H. Lee, M.-N. Lee, J.-W. Kim, Y.-H. Kim, M.J. Kim, et al. Complete sequence-based screening of tpmt variants in the korean population. 25(3),2015, pp. 143\u2013146.","DOI":"10.1097\/FPC.0000000000000117"},{"issue":"4","key":"10.1016\/j.bcp.2019.04.020_b0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00228-007-0426-x","article-title":"Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore","volume":"64","author":"Kham","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2019.04.020_b0045","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jcp.2009.069252","article-title":"Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come","volume":"63","author":"Ford","year":"2010","journal-title":"J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.bcp.2019.04.020_b0050","first-page":"397","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update","volume":"102","author":"Relling","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.bcp.2019.04.020_b0055","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/gut.2005.074930","article-title":"Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease","volume":"55","author":"Hindorf","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2019.04.020_b0060","doi-asserted-by":"crossref","unstructured":"E. Schaeffeler, C. Fischer, D. Brockmeier, D. Wernet, K. Moerike, M. Eichelbaum, et al. Comprehensive analysis of thiopurine s-methyltransferase phenotype-genotype correlation, in A Large Population of German-Caucasians And Identification of Novel Tpmt Variants. 14(2004) pp. 407\u2013417.","DOI":"10.1097\/01.fpc.0000114745.08559.db"},{"issue":"6","key":"10.1016\/j.bcp.2019.04.020_b0065","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.crohns.2011.11.014","article-title":"Genotyping should be considered the primary choice for pre-treatment evaluation of thiopurine methyltransferase function","volume":"6","author":"Hindorf","year":"2012","journal-title":"J. Crohn's Colitis"},{"issue":"9","key":"10.1016\/j.bcp.2019.04.020_b0070","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00228-013-1521-9","article-title":"Methotrexate binds to recombinant thiopurine S-methyltransferase and inhibits enzyme activity after high-dose infusions in childhood leukaemia","volume":"69","author":"Wennerstrand","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2019.04.020_b0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00007691-200206000-00005","article-title":"Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate","volume":"24","author":"Pettersson","year":"2002","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.bcp.2019.04.020_b0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1373\/clinchem.2003.023846","article-title":"Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease","volume":"50","author":"Haglund","year":"2004","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2019.04.020_b0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/dna.1996.15.17","article-title":"Thiopurine methyltransferase pharmacogenetics: Human gene cloning and characterization of a common polymorphism","volume":"15","author":"Szumlanski","year":"1996","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bcp.2019.04.020_b0090","doi-asserted-by":"crossref","first-page":"46428","DOI":"10.1038\/srep46428","article-title":"One amino acid makes a difference-characterization of a new TPMT allele and the influence of SAM on TPMT stability","volume":"7","author":"Iu","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2019.04.020_b0095","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2133\/dmpk.DMPK-12-SC-008","article-title":"Detection of a novel single nucleotide polymorphism of the human thiopurine s-methyltransferase gene in a Chinese individual","volume":"27","author":"Lee","year":"2012","journal-title":"Drug Metabol. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.bcp.2019.04.020_b0100","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/pro.2809","article-title":"Robust and convenient analysis of protein thermal and chemical stability","volume":"24","author":"Niklasson","year":"2015","journal-title":"Protein Sci. A Publ. Protein Soc."},{"issue":"11","key":"10.1016\/j.bcp.2019.04.020_b0105","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/FPC.0b013e3283402ee4","article-title":"Characterization of a novel sequence variant, TPMT*28, in the human thiopurine methyltransferase gene","volume":"20","author":"Appell","year":"2010","journal-title":"Pharmacogenet. Genom."},{"issue":"4","key":"10.1016\/j.bcp.2019.04.020_b0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00008571-200404000-00006","article-title":"Identification of two novel sequence variants affecting thiopurine methyltransferase enzyme activity","volume":"14","author":"Lindqvist","year":"2004","journal-title":"Pharmacogenetics"},{"issue":"10","key":"10.1016\/j.bcp.2019.04.020_b0115","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/FPC.0b013e3282ef642b","article-title":"Explaining TPMT genotype\/phenotype discrepancy by haplotyping of TPMT*3A and identification of a novel sequence variant, TPMT*23","volume":"17","author":"Lindqvist","year":"2007","journal-title":"Pharmacogenet. Genom."},{"issue":"5","key":"10.1016\/j.bcp.2019.04.020_b0120","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.0306-5251.2001.01497.x","article-title":"Human thiopurine methyltransferase activity varies with red blood cell age","volume":"52","author":"Lennard","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2019.04.020_b0130","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/cpt.540","article-title":"Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: a meta-analysis of three genome-wide association studies","volume":"101","author":"Tamm","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.bcp.2019.04.020_b0135","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1182\/blood.V85.7.1897.bloodjournal8571897","article-title":"Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia","volume":"85","author":"McLeod","year":"1995","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bcp.2019.04.020_b0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00008571-199208000-00002","article-title":"Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes","volume":"2","author":"Szumlanski","year":"1992","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bcp.2019.04.020_b0145","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1258\/000456306778520070","article-title":"Whole-blood thiopurine s-methyltransferase activity with genotype concordance: a new, simplified phenotyping assay","volume":"5","author":"Ford","year":"2006","journal-title":".Ann. Clin. Biochem."},{"issue":"2","key":"10.1016\/j.bcp.2019.04.020_b0150","first-page":"89","article-title":"Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age","author":"Ganiere-Monteil","year":"2004","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.020_b0155","doi-asserted-by":"crossref","unstructured":"S.A. Coulthard, C. Rabello, J. Robson, C. Howell, L. Minto, P.G. Middleton et al., A comparison of molecular and enzyme-based assays for the detection of thiopurine methyltransferase mutations, 2000.","DOI":"10.1046\/j.1365-2141.2000.02218.x"},{"key":"10.1016\/j.bcp.2019.04.020_b0160","doi-asserted-by":"crossref","DOI":"10.1258\/000456303321016222","article-title":"Measurement of thiopurine S-methyltransferase activity in human blood samples based on high-performance liquid chromatography: reference values in erythrocytes from children","author":"Keizer-Garritsen","year":"2003","journal-title":"Ann Clin Biochem."},{"issue":"7","key":"10.1016\/j.bcp.2019.04.020_b0165","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3109\/00365519309092580","article-title":"Gender difference in red blood cell thiopurine methyltransferase activity","volume":"53","author":"Klemetsdal","year":"1993","journal-title":"Scand. J. Clin. Lab. Investig."},{"issue":"26","key":"10.1016\/j.bcp.2019.04.020_b0170","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1073\/pnas.0502352102","article-title":"Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation","volume":"102","author":"Wang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"30","key":"10.1016\/j.bcp.2019.04.020_b0175","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/bi300377d","article-title":"Structural characteristics determine the cause of the low enzyme activity of two thiopurine s-methyltransferase allelic variants: a biophysical characterization of TPMT*2 and TPMT*5","volume":"51","author":"Wennerstrand","year":"2012","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.bcp.2019.04.020_b0180","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1021\/acsomega.7b00801","article-title":"In vitro protein stability of two naturally occurring thiopurine s-methyltransferase variants: biophysical characterization of TPMT*6 and TPMT*8","volume":"2","author":"Wennerstrand","year":"2017","journal-title":"ACS Omega"},{"issue":"10","key":"10.1016\/j.bcp.2019.04.020_b0185","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1515\/cclm-2015-1170","article-title":"A point mutation in the thiopurine S-methyltransferase gene that led to exon 5 deletion in the transcribed mRNA","volume":"54","author":"Lee","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"issue":"7","key":"10.1016\/j.bcp.2019.04.020_b0190","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.bcp.2012.01.010","article-title":"Post-translational stabilization of thiopurine S-methyltransferase by S-adenosyl-l-methionine reveals regulation of TPMT*1 and *3C allozymes","volume":"83","author":"Milek","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2019.04.020_b0195","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2217\/pgs.14.84","article-title":"From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity","volume":"15","author":"Karas-Ku\u017eeli\u010dki","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"5","key":"10.1016\/j.bcp.2019.04.020_b0200","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/leu.2008.317","article-title":"Heterozygosity at the TPMT gene locus, augmented by mutated MTHFR gene, predisposes to 6-MP related toxicities in childhood ALL patients","volume":"23","author":"Karas-Kuzelicki","year":"2009","journal-title":"Leukemia"},{"issue":"21","key":"10.1016\/j.bcp.2019.04.020_b0205","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1093\/hmg\/dds302","article-title":"PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity","volume":"21","author":"Stocco","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.bcp.2019.04.020_b0210","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bjp.0702152","article-title":"Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population","volume":"125","author":"Spire-Vayron de la Moureyre","year":"1998","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2019.04.020_b0215","first-page":"189","article-title":"Characterization of a variable number tandem repeat region in the thiopurine S-methyltransferase gene promoter","volume":"9","author":"de la Moureyre","year":"1999","journal-title":"Pharmacogenet. Genom."},{"issue":"17","key":"10.1016\/j.bcp.2019.04.020_b0220","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2217\/pgs-2018-0123","article-title":"Novel motif of variable number of tandem repeats in TPMT promoter region and evolutionary association of variable number of tandem repeats with TPMT*3 alleles","volume":"19","author":"Urban\u010di\u010d","year":"2018","journal-title":"Pharmacogenomics"},{"issue":"7","key":"10.1016\/j.bcp.2019.04.020_b0225","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2217\/pme.12.85","article-title":"The pharmacogenetic basis of individual variation in thiopurine metabolism","volume":"9","author":"Blaker","year":"2012","journal-title":"Personal. Med."},{"issue":"4","key":"10.1016\/j.bcp.2019.04.020_b0230","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2125.1995.tb04478.x","article-title":"Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine","volume":"39","author":"Szumlanski","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2019.04.020_b0235","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1124\/dmd.107.016287","article-title":"Inhibition of human thiopurine S-methyltransferase by various nonsteroidal anti-inflammatory drugs in vitro: a mechanism for possible drug interactions","volume":"35","author":"Oselin","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.bcp.2019.04.020_b0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00008571-200302000-00006","article-title":"Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype in British Asians and Caucasians","volume":"13","author":"Marinaki","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bcp.2019.04.020_b0245","first-page":"925","article-title":"PACSIN2 Does not influence thiopurine-related toxicity in patients with inflammatory bowel","volume":"109","author":"Roberts","year":"2014","journal-title":"Disease"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219301558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219301558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:07:53Z","timestamp":1757768873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219301558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":48,"alternative-id":["S0006295219301558"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.04.020","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive study of thiopurine methyltransferase genotype, phenotype, and genotype-phenotype discrepancies in Sweden","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}